Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N
Open Access
- 1 February 2002
- journal article
- Published by Wiley in Microbiology and Immunology
- Vol. 46 (2), 131-134
- https://doi.org/10.1111/j.1348-0421.2002.tb02669.x
Abstract
Pro‐carboxypeptidase R (proCPR), also known as thrombin‐activatable fibrinolysis inhibitor (TAFI), precursor of carboxypeptidase U and plasma carboxypeptidase B is present in plasma and following activation by thrombin/thrombomodulin and/or plasmin can remove arginine from the carboxyterminal of C3a and C5a. We have shown that this enzyme can remove terminal arginine from the C5a octapeptide much more efficiently than the classical anaphylatoxin inactivator, carboxypeptidase N (CPN). Since we have previously demonstrated that proCPR is significantly upregulated in the inflammatory state, this enzyme would appear to significantly contribute to the inactivation of C5a, the most potent of the complement derived anaphylatoxins.Keywords
This publication has 16 references indexed in Scilit:
- Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1995
- Pro-Carboxypeptidase R Cleaves Bradykinin following ActivationInternational Archives of Allergy and Immunology, 1994
- Evaluation of the C‐terminal C5a effector site with short synthetic C5a analog peptidesEuropean Journal of Immunology, 1993
- Decay Accelerating Factor (CD55)Published by Springer Nature ,1992
- An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunitsBiochemical and Biophysical Research Communications, 1989
- Protamine Inhibits Plasma Carboxypeptidase N, the Inactivator of Anaphylatoxins and KininsAnesthesiology, 1989
- Basic carboxypeptidases: regulators of peptide hormone activityTrends in Pharmacological Sciences, 1988
- Restriction of alternative complement pathway activation by sialosylglycolipidsNature, 1982
- Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.The Journal of Experimental Medicine, 1981